GlassScriptPhysician profile
Kristin Patton
NPI 1770745523
$7,230.09
in general payments reported to CMS, 2019-2025
20 companies · $285 in 2025
The $285 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,432 · 2020: $94.90 · 2021: $139 · 2022: $325 · 2023: $2,055 · 2024: $1,899 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,501 · Travel and Lodging: $1,706 · Gift: $32.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,501.15 |
| Travel and Lodging | $1,705.53 |
| Gift | $32.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,749.05 | 2019-2025 | Gore Synecor Biomaterial, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Intuitive Surgical, INC. | $2,034.66 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $1,363.48 | 2024 | Ligasure, Signia, Eea |
| Ethicon US, LLC | $239.03 | 2019-2024 | Echelon Flex, Vistaseal, Echelon Circular |
| Apollo Endosurgery US INC | $231.79 | 2019-2023 | Overstitch Endoscopic Suturing System |
| Novo Nordisk INC | $134.66 | 2019-2024 | Wegovy, Saxenda |
| Boston Scientific Corporation | $127.03 | 2024 | |
| Innovation Technologies INC | $49.14 | 2022-2024 | Irrisept |
| Acera Surgical, INC. | $46.78 | 2019-2020 | |
| Baxter Healthcare | $46.42 | 2019 | |
| Teleflex LLC | $39.73 | 2022-2025 | Titan Sgs Bailout Chuck |
| Davol INC. | $26.00 | 2019 | |
| Ambu INC. | $24.14 | 2023 | |
| Polynovo North America LLC | $23.81 | 2024 | Novosorb Btm |
| Glaxosmithkline, LLC. | $19.64 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $17.14 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.95 | 2020 | |
| Endo Pharmaceuticals INC. | $15.53 | 2021 | |
| Currax Pharmaceuticals LLC | $13.62 | 2023 | Contrave |
| Astellas Pharma US INC | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Patton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.